Organogenesis Holdings Inc (NASDAQ:ORGO) shares, rose in value, with the stock price up by 19.25% to the previous day’s close as strong demand from buyers drove the stock to $6.01.
Actively observing the price movement in the last trading, the stock closed the session at $5.04. The PE ratio was 1073.21 over 12-month period. Referring to stock’s 52-week performance, its high was $6.71, and the low was $2.16. On the whole, ORGO has fluctuated by 76.25% over the past month.
With the market capitalization of Organogenesis Holdings Inc currently standing at about $762.23 million, investors are eagerly awaiting this quarter’s results, scheduled for in April.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 488.25M, with a low estimate of 87.7M and a high estimate of 93.8M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 90.77M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ORGO’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of ORGO currently trading nearly 54.14% and 69.54% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 69.85, while the 7-day volatility ratio is showing 24.28% which for the 30-day chart, stands at 8.96%. Furthermore, Organogenesis Holdings Inc (ORGO)’s beta value is 1.73, and its average true range (ATR) is 0.50.
A comparison of Organogenesis Holdings Inc (ORGO) with its peers suggests the former has fared considerably weaker in the market. ORGO showed an intraday change of 19.25% in last session, and over the past year, it grew by 105.82%%.
Data on historical trading for Organogenesis Holdings Inc (NASDAQ:ORGO) indicates that the trading volumes over the past 3 months, they’ve averaged 1.63 million. According to company’s latest data on outstanding shares, there are 125.73 million shares outstanding.
Nearly 49.26% of Organogenesis Holdings Inc’s shares belong to company insiders and institutional investors own 49.46% of the company’s shares. The stock has risen by 87.81% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ORGO stock heading into the next quarter.
